Suchergebnisse - (Standardsuche:issn:"1568-0096" OR issn:"1873-5576")

PubPharm (10)

1

Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies

enthalten in: Current cancer drug targets | 2024

von Mohite, R. | Doshi, G.

2

CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK

enthalten in: Current cancer drug targets | 2019

von Liang, C. | Zhang, N. | Tan, Q. | +5

3

Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in Cancer

enthalten in: Current cancer drug targets | 2018

von Akhtar, N. | Jabeen, I.

4

Novel agents, combinations and sequences for the treatment of advanced renal cell carcinoma : When is the revolution coming?

enthalten in: Current cancer drug targets | 2013

von Santoni, M. | Rizzo, M. | Burattini, L. | +3

5

Targeting the mTOR pathway in tumor malignancy

enthalten in: Current cancer drug targets | 2013

von Cheng, H. | Walls, M. | Baxi, S. | +1

6

Mechanistic insights into the antileukemic activity of hyperforin

enthalten in: Current cancer drug targets | 2013

von Billard, C. | Merhi, F. | Bauvois, B.

7

Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments : concordance with experimental results

enthalten in: Current cancer drug targets | 2010

von Castagnino, N. | Tortolina, L. | Balbi, A. | +7

8

The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications

enthalten in: Current cancer drug targets | 2008

von Carnero, A. | Blanco-Aparicio, C. | Renner, O. | +2

9

The PI3K/Akt pathway : recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors

enthalten in: Current cancer drug targets | 2008

von Lindsley, C. | Barnett, S. | Layton, M. | +1

10

Deregulation of the Akt pathway in human cancer

enthalten in: Current cancer drug targets | 2008

von Tokunaga, E. | Oki, E. | Egashira, A. | +4

1
[1]